JP2019510768A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019510768A5 JP2019510768A5 JP2018550320A JP2018550320A JP2019510768A5 JP 2019510768 A5 JP2019510768 A5 JP 2019510768A5 JP 2018550320 A JP2018550320 A JP 2018550320A JP 2018550320 A JP2018550320 A JP 2018550320A JP 2019510768 A5 JP2019510768 A5 JP 2019510768A5
- Authority
- JP
- Japan
- Prior art keywords
- hydroxynorketamine
- crystalline form
- gamma
- lattice
- beta
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022041167A JP7379567B2 (ja) | 2016-03-25 | 2022-03-16 | （２ｒ，６ｒ）－ヒドロキシノルケタミンおよび（２ｓ，６ｓ）－ヒドロキシノルケタミンの結晶形態および合成方法 |
| JP2023208374A JP2024015334A (ja) | 2016-03-25 | 2023-12-11 | （２ｒ，６ｒ）－ヒドロキシノルケタミンおよび（２ｓ，６ｓ）－ヒドロキシノルケタミンの結晶形態および合成方法 |
| JP2026037915A JP2026094402A (ja) | 2016-03-25 | 2026-03-10 | ノルケタミンをキラル分割するための方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662313309P | 2016-03-25 | 2016-03-25 | |
| US62/313,309 | 2016-03-25 | ||
| PCT/US2017/024241 WO2017165878A1 (en) | 2016-03-25 | 2017-03-27 | Crystal forms and methods of synthesis of (2r, 6r)-hydroxynorketamine and (2s, 6s)-hydroxynorketamine |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022041167A Division JP7379567B2 (ja) | 2016-03-25 | 2022-03-16 | （２ｒ，６ｒ）－ヒドロキシノルケタミンおよび（２ｓ，６ｓ）－ヒドロキシノルケタミンの結晶形態および合成方法 |
| JP2023208374A Division JP2024015334A (ja) | 2016-03-25 | 2023-12-11 | （２ｒ，６ｒ）－ヒドロキシノルケタミンおよび（２ｓ，６ｓ）－ヒドロキシノルケタミンの結晶形態および合成方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019510768A JP2019510768A (ja) | 2019-04-18 |
| JP2019510768A5 true JP2019510768A5 (enExample) | 2020-05-07 |
| JP7603368B2 JP7603368B2 (ja) | 2024-12-20 |
Family
ID=58503714
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018550320A Active JP7603368B2 (ja) | 2016-03-25 | 2017-03-27 | （２ｒ，６ｒ）－ヒドロキシノルケタミン塩酸塩の結晶形態 |
| JP2022041167A Active JP7379567B2 (ja) | 2016-03-25 | 2022-03-16 | （２ｒ，６ｒ）－ヒドロキシノルケタミンおよび（２ｓ，６ｓ）－ヒドロキシノルケタミンの結晶形態および合成方法 |
| JP2023208374A Pending JP2024015334A (ja) | 2016-03-25 | 2023-12-11 | （２ｒ，６ｒ）－ヒドロキシノルケタミンおよび（２ｓ，６ｓ）－ヒドロキシノルケタミンの結晶形態および合成方法 |
| JP2026037915A Pending JP2026094402A (ja) | 2016-03-25 | 2026-03-10 | ノルケタミンをキラル分割するための方法 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022041167A Active JP7379567B2 (ja) | 2016-03-25 | 2022-03-16 | （２ｒ，６ｒ）－ヒドロキシノルケタミンおよび（２ｓ，６ｓ）－ヒドロキシノルケタミンの結晶形態および合成方法 |
| JP2023208374A Pending JP2024015334A (ja) | 2016-03-25 | 2023-12-11 | （２ｒ，６ｒ）－ヒドロキシノルケタミンおよび（２ｓ，６ｓ）－ヒドロキシノルケタミンの結晶形態および合成方法 |
| JP2026037915A Pending JP2026094402A (ja) | 2016-03-25 | 2026-03-10 | ノルケタミンをキラル分割するための方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US10919842B2 (enExample) |
| EP (1) | EP3433230A1 (enExample) |
| JP (4) | JP7603368B2 (enExample) |
| CN (2) | CN109311801B (enExample) |
| AU (1) | AU2017238859B2 (enExample) |
| CA (2) | CA3018959C (enExample) |
| WO (1) | WO2017165878A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107847469A (zh) | 2015-06-27 | 2018-03-27 | 美国神农制药责任有限公司 | 氯胺酮透皮递送系统 |
| AU2017238859B2 (en) | 2016-03-25 | 2021-02-18 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamine |
| AU2017250086A1 (en) * | 2016-04-11 | 2018-09-20 | Clexio Biosciences Ltd. | Deuterated ketamine derivatives |
| CN110343050B (zh) * | 2018-04-04 | 2021-09-24 | 上海键合医药科技有限公司 | 芳香类化合物及其制备方法和用途 |
| US11186539B2 (en) | 2018-06-04 | 2021-11-30 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Process for synthesis and purification of (2R,6R)-hydroxynorketamine |
| CN112299972B (zh) * | 2019-08-02 | 2023-03-14 | 扬子江药业集团有限公司 | 一种高纯度盐酸艾司氯胺酮酮体的制备方法 |
| AU2020387937B2 (en) * | 2019-11-18 | 2026-06-18 | The United States Government As Represented By The Department Of Veterans Affairs | Salts of (2R, 6R)-hydroxynorketamine, their crystal forms, and methods of making the same |
| WO2022041175A1 (zh) * | 2020-08-31 | 2022-03-03 | 深圳瑞健生物科技有限公司 | 一种长效低成瘾性hnk衍生物在制备药物中的应用 |
| US12466785B2 (en) | 2020-08-31 | 2025-11-11 | Shenzhen Ruijian Biotechnology Co., Ltd | Long-acting low-addiction HNK derivative and preparation method therefor |
| KR102906446B1 (ko) * | 2020-08-31 | 2026-01-02 | 선전 루이지엔 바이오테크놀로지 컴퍼니 리미티드 | 장기 작용성 및 저중독성 hnk 유도체 및 그의 제조 방법 |
| CN112521295B (zh) * | 2020-08-31 | 2021-10-08 | 深圳瑞健生物科技有限公司 | 一种长效低成瘾性化合物及其制备方法 |
| CN112516130B (zh) * | 2020-08-31 | 2022-01-04 | 深圳瑞健生物科技有限公司 | 一种长效低成瘾性化合物在制备药物中的应用 |
| CN112521358B (zh) * | 2020-08-31 | 2021-10-08 | 深圳瑞健生物科技有限公司 | 一种长效低成瘾性hnk衍生物在制备药物中的应用 |
| WO2022041172A1 (zh) * | 2020-08-31 | 2022-03-03 | 深圳瑞健生物科技有限公司 | 一种长效低成瘾性化合物在制备药物中的应用 |
| CN112521357B (zh) * | 2020-08-31 | 2021-10-08 | 深圳瑞健生物科技有限公司 | 一种长效低成瘾性hnk衍生物及其制备方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK532575A (da) * | 1974-12-13 | 1976-06-14 | Merck & Co Inc | Fremgangsmade til racematspaltning af organiske forbindelser |
| US20070185346A1 (en) | 2006-02-03 | 2007-08-09 | Vaidya Niteen A | Kit for automated resolving agent selection and method thereof |
| WO2009131794A1 (en) * | 2008-03-27 | 2009-10-29 | University Of Kentucky Research Foundation | Opioid-ketamine and norketamine codrug combinations for pain management |
| JP6296985B2 (ja) * | 2011-10-14 | 2018-03-20 | ザ ユナイテッド ステイツ オブ アメリカ， アズ リプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ | うつ病及び神経障害性疼痛の治療における（２ｒ，６ｒ）−ヒドロキシノルケタミン、（ｓ）−デヒドロノルケタミン及び他の（ｒ，ｓ）−ケタミンの立体異性デヒドロ及びヒドロキシル化代謝生成物の使用 |
| US20140079740A1 (en) * | 2012-08-02 | 2014-03-20 | ClinPharm Support GmbH | Oral transmucosal adminstration forms of s-ketamine |
| AU2013328280B2 (en) | 2012-10-08 | 2017-12-21 | Auckland Uniservices Limited | Ketamine derivatives |
| US9096537B1 (en) * | 2014-12-31 | 2015-08-04 | Mahesh Kandula | Compositions and methods for the treatment of mucositis |
| US20190083420A1 (en) * | 2016-03-25 | 2019-03-21 | The Uinited States of America, as represented by the Secretary, Department of Health and Human Serv | Methods of using (2r, 6r)-hydroxynorketamine and (2s, 6s)-hydroxynorketamine in the treatment of depression, anxiety, anhedonia, fatigue, suicidal ideation, and post traumatic stress disorders |
| AU2017238859B2 (en) | 2016-03-25 | 2021-02-18 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamine |
| EP3505509A1 (en) | 2017-12-29 | 2019-07-03 | Université de Liège | Methods for the preparation of arylcycloalkylamine derivatives |
-
2017
- 2017-03-27 AU AU2017238859A patent/AU2017238859B2/en active Active
- 2017-03-27 US US16/088,371 patent/US10919842B2/en active Active
- 2017-03-27 WO PCT/US2017/024241 patent/WO2017165878A1/en not_active Ceased
- 2017-03-27 JP JP2018550320A patent/JP7603368B2/ja active Active
- 2017-03-27 CN CN201780027680.8A patent/CN109311801B/zh active Active
- 2017-03-27 CN CN202210826464.2A patent/CN115108927A/zh active Pending
- 2017-03-27 EP EP17716350.8A patent/EP3433230A1/en active Pending
- 2017-03-27 CA CA3018959A patent/CA3018959C/en active Active
- 2017-03-27 CA CA3228060A patent/CA3228060A1/en active Pending
-
2021
- 2021-01-22 US US17/155,162 patent/US11613514B2/en active Active
-
2022
- 2022-03-16 JP JP2022041167A patent/JP7379567B2/ja active Active
-
2023
- 2023-02-16 US US18/170,048 patent/US12473251B2/en active Active
- 2023-12-11 JP JP2023208374A patent/JP2024015334A/ja active Pending
-
2026
- 2026-03-10 JP JP2026037915A patent/JP2026094402A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018024682A5 (enExample) | ||
| IL296199B2 (en) | Salt form of a human hi stone methyltransf erase ezh2 inhibitor | |
| EP4356736A3 (en) | Synthesis of boronate salts | |
| HRP20171151T1 (hr) | Inhibitori cdc7 | |
| HRP20211670T1 (hr) | Derivat difenilmetana u kristalnom obliku | |
| JP2016041720A5 (enExample) | ||
| JP2015010091A5 (enExample) | ||
| JP2016065042A5 (enExample) | ||
| RU2016146119A (ru) | Новый кристалл тетрациклического соединения | |
| JP2018035160A5 (enExample) | ||
| WO2014136282A8 (en) | Crystalline form having specific crystal habit and pharmaceutical composition containing this crystalline form as active ingredient | |
| JP2015531000A5 (enExample) | ||
| WO2014209841A3 (en) | Compounds for treating spinal muscular atrophy | |
| JP2014526498A5 (enExample) | ||
| JP2012512885A5 (enExample) | ||
| MX381000B (es) | Cristales de compuesto azabicíclico. | |
| HRP20230813T1 (hr) | Upadacitinib solni spoj i postupak njegove pripreme | |
| JP2012531408A5 (enExample) | ||
| WO2015017378A3 (en) | Novel copper-cysteamine and methods of use | |
| JO3178B1 (ar) | النموذج السادس البلوري الجديد من مركب الاغوميلاتين وطريقة تحضيره وتحضير المركبات الصيدلانية المحتوية عليه | |
| WO2015000431A9 (zh) | 替唑尼特氨基甲酸酯及其在药学中的应用 | |
| GEP20125433B (en) | α CRYSTALLINE FORM OF THE ARGININE SALT OF PERINDOPRIL, PROCESS FOR PREPARING IT, AND PHARMACEUTICAL COMPOSITIONS COMPRISING IT | |
| JP2015534725A5 (enExample) | ||
| JP2015506941A5 (enExample) | ||
| JP2016515550A5 (enExample) |